← Leaderboards
Yan Zhang
Case Western Reserve University
$109,736
Attributed
$109,736
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$109,736 · 2
By mechanism
F32$109,390 · 1
P41$346 · 1
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Julian Stelzer$9,895,616
- Cheng-Ming Chiang$10,180,970
- Anita C Gilliam$2,181,316
- Zhongwu Guo$9,004,232
- Peter Scott Heeger$92,873,534
Others in their field
Top investigators on “Transforming Growth Factors”
- J. Mark Cline · Wake Forest University$19,830,326
- Martin M Matzuk · University Of Missouri-Columbia$19,151,455
- Joan Massague · Sloan-Kettering Institute For Cancer Res$17,872,570
- Xu Cao · Johns Hopkins University$16,160,002
- Jae U Jung · Cleveland Clinic Lerner Com-Cwru$15,688,012
- Kathryn M Anastos · Montefiore Medical Center (Bronx, Ny)$15,465,311
Research focus
Transforming Growth FactorsInhibitor /AntagonistPolymerase Chain ReactionSclerodermaFibroblastsCellular PathologyMonocyteNonhuman Therapy EvaluationDisease /Disorder ModelProtein IsoformsCollagenFlow CytometryFluorescent In Situ HybridizationCell MigrationLaboratory MouseMacrophageGraft Versus Host DiseaseNatural Killer CellsImmunocytochemistryImmunotherapyFundingInstitutionComplexInhibitor/Antagonist
Grant awards (4)
DEPHOSPHORYLATION REGULATION OF TRANSCRIPTION BY CTD PHOSPHATASES$346
P41 · FY2010 · RR · contact PI
INHIBITION OF EFFECTOR CELLS IN SCLERODERMATOUS GVHD$29,878
F32 · FY2002 · AR
INHIBITION OF EFFECTOR CELLS IN SCLERODERMATOUS GVHD$41,996
F32 · FY2001 · AR
INHIBITION OF EFFECTOR CELLS IN SCLERODERMATOUS GVHD$37,516
F32 · FY2000 · AR